Cellular senescence and the senescence-associated secretory phenotype: Potential therapeutic targets for renal fibrosis

Exp Gerontol. 2021 May 10:111403. doi: 10.1016/j.exger.2021.111403. Online ahead of print.ABSTRACTRenal fibrosis plays a crucial role in the progression of chronic kidney disease and end-stage renal disease. However, because the aetiology of this pathological process is complex and remains unclear, there is still no effective treatment. Cellular senescence and the senescence-associated secretory phenotype (SASP) have been reported to lead to renal fibrosis. This review first discusses the relationships among cellular senescence, the SASP and renal fibrosis. Then, the key role of the SASP in irreversible renal fibrosis, including fibroblast activation and abnormal extracellular matrix accumulation, is discussed, with the results of studies having indicated that inhibiting cellular senescence and the SASP might be a potential preventive and therapeutic strategy for renal fibrosis. Finally, we summarize promising therapeutic strategies revealed by existing research on senescent cells and the SASP, including emerging interventions targeting the SASP, caloric restriction and mimetics, and novel regeneration therapies with stem cells.PMID:33984448 | DOI:10.1016/j.exger.2021.111403
Source: Experimental Gerontology - Category: Geriatrics Authors: Source Type: research